Nocturnal Parkinson's Disease Symptoms Study Group

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Roongroj Bhidayasiri, Chulalongkorn University
ClinicalTrials.gov Identifier:
NCT01662427
First received: August 7, 2012
Last updated: August 18, 2013
Last verified: August 2013
  Purpose

To study associate factor of Noctural Parkinson's Disease Symptoms and quality of life in Parkinson's disease patients and caregivers.


Condition Intervention
Parkinson's Disease
Other: Questionaire to assess Noctural Parkinson's Disease Symptoms

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Nocturnal Parkinson's Disease Symptoms Study Group

Resource links provided by NLM:


Further study details as provided by Chulalongkorn University:

Primary Outcome Measures:
  • To assess Noctural Parkinson's Disease Symptoms [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To assess quality of life in Parkinson's Disease patient [ Designated as safety issue: No ]
  • To assess quality of life in caregiver of Parkinson's Disease patient [ Designated as safety issue: No ]

Enrollment: 300
Study Start Date: November 2012
Study Completion Date: August 2013
Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Questionniare Other: Questionaire to assess Noctural Parkinson's Disease Symptoms
Questionaire to assess Noctural Parkinson's Disease Symptoms and quality of life

  Eligibility

Ages Eligible for Study:   30 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Parkinson's disease patient and care givers

Criteria

Inclusion Criteria:

Idiopathic Parkinson's disease patient

Exclusion Criteria:

  1. Patient with Secondary Parkinsonism eg.Drug-induced Parkinsonism, Vascular Parkinsonism, exposure to toxin, Encephalitis
  2. Patient with Atypical Parkinsonial Syndromes eg. Parkinson-plus syndrome, Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
  3. Patient with Heredodegenerative parkinsonism eg. Spinocerebellar ataxias, Wilson's disease, Juvenile Huntington's disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01662427

Locations
Thailand
Roongroj Bhidayasiri
Pathumwan, Bangkok, Thailand, 10330
Sponsors and Collaborators
Chulalongkorn University
  More Information

No publications provided

Responsible Party: Roongroj Bhidayasiri, Associate Professor, Chulalongkorn University
ClinicalTrials.gov Identifier: NCT01662427     History of Changes
Other Study ID Numbers: 6222012
Study First Received: August 7, 2012
Last Updated: August 18, 2013
Health Authority: Thailand: Ethical Committee

Keywords provided by Chulalongkorn University:
Quality of life
Noctural Parkinson's Disease Symptoms

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on August 19, 2014